Shared Research logo
Concluded contract manufacturing agreement with Fuso Pharmaceutical Industries
Full-year FY04/22 flash update
Booking of non-operating income, non-operating expenses, and extraordinary loss; revision of FY04/22 forecast
Get in touch
Kojimachi HF Building 7th floor3- 2- 4 Kojimachi Chiyoda-ku Tokyo, Japan 102-0083
Medical technology company. Exclusively licensed from MIT, core technology is based on unique characteristics of self-assembling peptides.